Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1998-9-3
|
| pubmed:abstractText |
We compared the immunogenicity of 7-valent pneumococcal-conjugate vaccine plus 23-valent pneumococcal vaccine to immunization with 23-valent vaccine only in individuals > or = 2 years of age with sickle cell disease. IgG pneumococcal antibody concentrations were higher in the combined schedule group with no increase in side effects observed after immunization with 23-valent vaccine.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0022-3476
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
133
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
275-8
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:9709721-Adolescent,
pubmed-meshheading:9709721-Adult,
pubmed-meshheading:9709721-Anemia, Sickle Cell,
pubmed-meshheading:9709721-Antibodies, Bacterial,
pubmed-meshheading:9709721-Bacterial Vaccines,
pubmed-meshheading:9709721-Child,
pubmed-meshheading:9709721-Child, Preschool,
pubmed-meshheading:9709721-Drug Administration Schedule,
pubmed-meshheading:9709721-Female,
pubmed-meshheading:9709721-Humans,
pubmed-meshheading:9709721-Male,
pubmed-meshheading:9709721-Streptococcus pneumoniae,
pubmed-meshheading:9709721-Vaccines, Conjugate
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease.
|
| pubmed:affiliation |
Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|